50
Participants
Start Date
January 21, 2021
Primary Completion Date
April 30, 2024
Study Completion Date
April 30, 2024
Fludarabine
30 mg/m2/day iv x 6 days, days -7 through -2 of HSCT
Bendamustine Hydrochloride
130 mg/m2 iv x 2 days, Days -7 through -6 of HSCT
Busulfan
1 mg/kg po qid x 3 days, Days -5 through -3
Cyclophosphamide
50 mg/kg iv x 2 days, Days +3 through +4
Mycophenolate Mofetil
45 mg/kg/day, maximum 3 g/day, iv or po x 30 days, Days +5 through +35
Tacrolimus 5Mg Cap
0.03 mg/kg/day iv or po, Days +5 through +100 with with further correction by concentration. Target concentration 5-15 ng/ml.
RM Gorbacheva Research Institute, Saint Petersburg
St. Petersburg State Pavlov Medical University
OTHER